Prudential Financial Inc Provention Bio, Inc. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$6.7 - $24.21 $2,010 - $7,263	300 Added 0.88%	34,250 $825,000
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $2,033 - $4,756	450 Added 1.34%	33,950 $0
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $122,275 - $244,550	33,500 New	33,500 $134,000
Q1 2022 May 13, 2022	SELL	$3.4 - $7.88 $86,020 - $199,364	-25,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $141,427 - $186,967	25,300 New	25,300 $142,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.